Hemostasis combo product
This article was originally published in The Gray Sheet
Executive Summary
A hemostasis kit for controlling bleeding during surgical procedures that combines Baxter's human thrombin with Pfizer's Gelfoam gelatin absorbable sponge receives FDA approval Dec. 17. The firms signed a marketing, supply and manufacturing agreement on the Gelfoam Plus kit that gives Baxter exclusive distribution rights. The combination product is indicated for use when conventional hemostatic methods are ineffective or impractical